1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow FGFR2 Gene Translocation: new trials by email Literature Review of FGFR2 Gene Translocation trials Research Report on FGFR2 Gene Translocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors RLY-4008 - FGFR2 Amplification, FGFR2 Gene Mutation | Phase 1 / Phase 2 | Completed | Elevar Therapeutics | 490 | 2020-09-02 | 2026-02-27 |
Adenocarcinoma (1) · Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Australia (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Spain (1) · Sweden (1) · Taiwan (1) · United Kingdom (1) · United States (1)